Why Healthy People Are Wearing Continuous Glucose Monitors

You eat what you think is a healthy meal—grilled salmon, brown rice, and roasted vegetables. An hour later, you feel sluggish, foggy, and inexplicably hungry again. For years, most people chalked this afternoon crash up to stress, poor sleep, or simply the cost of doing business in a busy world. Today, a growing cohort of health-conscious individuals are looking at their smartphones to blame a different culprit: a hidden blood sugar spike.[6]

The device driving this revelation is the continuous glucose monitor (CGM). Once strictly a prescription medical device reserved for managing type 1 and type 2 diabetes, the CGM has rapidly crossed over into the mainstream consumer wellness market. What was once a specialized tool for preventing dangerous hypoglycemic emergencies is now being embraced by athletes, biohackers, and everyday professionals seeking to optimize their daily energy levels.[3][6]

The regulatory floodgates for this consumer shift opened in March 2024, when the U.S. Food and Drug Administration (FDA) cleared the Dexcom Stelo as the first over-the-counter (OTC) continuous glucose monitor. Intended for adults 18 and older who do not use insulin, the Stelo was quickly followed by Abbott's Lingo, a competing device explicitly cleared as a general health and wellness tool rather than a strict diabetes management system.[1][4]

By 2026, these devices have become as ubiquitous in certain fitness circles as smartwatches and sleep trackers. But this transition from reactive medical treatment to proactive metabolic optimization raises a fundamental question that has divided the medical community: does a metabolically healthy person actually need to track their blood sugar in real time?[3][6]

To understand the debate, it helps to understand the mechanism. A CGM does not actually measure blood. Instead, a user applies a small, quarter-sized patch to the back of their upper arm or abdomen. A tiny, flexible filament sits just under the skin, measuring glucose levels in the interstitial fluid—the fluid that naturally surrounds the body's cells.[3]

The sensor takes a reading every few minutes and transmits the data wirelessly to a paired smartphone app. Unlike a traditional fingerstick test that provides a single, isolated snapshot in time, a CGM offers a continuous, 24-hour motion picture of a user's metabolic response to food, exercise, stress, and sleep. Users typically wear a single sensor for 10 to 15 days before replacing it.[1][3][4]

For non-diabetics, the primary appeal of this data lies in the pursuit of "metabolic flexibility"—the body's ability to efficiently switch between burning carbohydrates and burning fat for fuel. Proponents argue that standard medical testing often misses early warning signs of metabolic dysfunction, leaving patients in the dark until they officially cross the threshold into prediabetes.[5][6]

A routine blood panel might show a perfectly normal fasting glucose level, even while a person experiences massive, dysregulated glucose spikes and crashes after meals. Research published in the ACNEM Journal highlights this blind spot: in one study of 665 healthy individuals wearing CGMs, 15 percent experienced glucose excursions into the diabetic range, and 36 percent spiked into the pre-diabetic range.[5]

For many users, the most powerful benefit of an OTC CGM is simply behavioral psychology. Seeing a real-time graph of your glucose climbing rapidly after eating a bowl of pasta is a far more visceral trigger for behavior change than reading a generic nutrition guideline. Users often naturally adjust their diets, opting for more protein, fiber, and post-meal walks to "flatten the curve" of their blood sugar.[4][6]

However, the traditional medical community remains highly skeptical of the clinical utility of this data for the general public. Endocrinologists caution that a blood sugar spike after eating carbohydrates is not inherently dangerous—it is a normal, healthy physiological response that the human body is perfectly equipped to handle.[4]

"Right now, there's no solid evidence that continuous glucose monitors offer clear benefits for people without diabetes," noted Dr. Michael Natter, an endocrinologist at NYU Langone Health, in an interview with Popular Science. While the technology is undeniably powerful, the long-term science linking flattened glucose curves in healthy people to actual disease prevention is still emerging.[2][3]

There is also a documented psychological downside to the biohacking trend. Experts warn that providing highly granular, real-time data without proper medical context can lead to unnecessary anxiety. Some users develop orthorexic tendencies, intentionally withholding food or avoiding perfectly healthy fruits and complex carbohydrates simply because they cause a temporary, harmless rise in the app's graph.[2][4]

To mitigate these risks, OTC devices like the Dexcom Stelo and Abbott Lingo are intentionally limited compared to their prescription counterparts. They do not feature the low-glucose alarms that are critical for insulin users, and they often measure a narrower range of glucose values, reinforcing their status as lifestyle tools rather than diagnostic medical instruments.[1][4]

The market has responded to this need for context by pairing the hardware with specialized software. A wave of health-tech startups now offer direct-to-consumer programs that integrate OTC CGM data with personalized coaching, helping users interpret their spikes and make sustainable lifestyle changes rather than panicking over a single high reading.[3][6]

Ultimately, the rise of the OTC continuous glucose monitor represents a broader cultural shift toward personalized, data-driven healthcare. For those with unexplained fatigue, a family history of metabolic disease, or a genuine curiosity about their unique biology, a short-term trial of a CGM can be genuinely illuminating. But for the metabolically healthy, it remains a fascinating tool for self-discovery rather than a strict medical necessity.[3][6]